Topic Biomarkers
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Biomarker-Driven Cancer Care Is Not Reaching All Americans
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0920Published: September 2020Expires: 9/1/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Biomarkers , Cancer Therapies -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Biomarker-Driven Cancer Care Is Not Reaching All Americans ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0920Published: September 2020Expires: 9/1/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Biomarkers , Cancer Therapies -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Review of CSF and Serum Biomarkers to Stratify Acute Spinal Cord Injury Based on Severity of Injury and Prognosis - Vol. 21, Vol. 1
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CSS0120Published: January 2020Expires: 12/31/2021Sources: Contemporary Spine SurgeryDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Study Tracks Accelerating Use of Biomarkers in Cancer Clinical Trials
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1219Published: December 2019Expires: 12/3/2021Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Study Tracks Accelerating Use of Biomarkers in Cancer Clinical Trials ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN1219Published: December 2019Expires: 12/3/2021Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Relevant Biomarkers for the Treatment of Hematological Malignancies
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0919Published: September 2019Expires: 8/31/2021Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: OncologySpecialties: Hematology, OncologyTopics: Biomarkers -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Relevant Biomarkers for the Treatment of Hematological Malignancies ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0919Published: September 2019Expires: 8/31/2021Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: OncologySpecialties: Hematology, OncologyTopics: Biomarkers